BEKE Q4 2025 Earnings EPS Misses Estimates as Stock Drops Over 6 Catalyst Pharmaceuticals Q1 2026 Earnings EPS Surpasses Estimates by 75 TBBB Q1 2026 Earnings Narrowly Misses Estimates Stock Flat QVCGP Q3 2025 Earnings Preferred Stock Reports Significant Loss Amid Ongoing Operational Challenges MGA Q1 2026 Earnings Strong Earnings Beat Drives Share Price Higher ANIK Q1 2026 Earnings Surprise Profit Swing as Anika Therapeutics Beats Expectations SLXN Q1 2026 Earnings NarrowerThanExpected Loss Drives Surprise but Stock Declines